Remove Physicals Remove Presentation Remove Screening Remove Transportation
article thumbnail

Why are So Many Teens and 20-Somethings Today Anxiety-Ridden?

Doctor Rachel

All artificial light has the result of reducing melatonin production at night and making sleep more difficult, but the light on computer and phone screens is a bluer light, and it has twice the suppressive effect on melatonin — severely impairing sleep in teens. The impact of less sleep? Well, increased stress hormones.

Screening 130
article thumbnail

Logistics Unwrapped: A Roadmap to Successful FDA Meetings in In-Person and Hybrid Formats

FDA Law Blog

CDRH recently announced its acceptance and hosting of in-person meetings, including hybrid options that allow for both physical and virtual participation. If you are driving, stop at the vehicle screening facility and inform security that you are attending a meeting. Getting to Building 66 Most CDRH meetings occur in Building 66.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Time to stop driving? Podcast with Emmy Betz and Terri Cassidy

GeriPal

Or somebody who has other physical cognitive problems at any age. And I’ve been to some presentations that use that same breaking bad news model for having these driving conversations, as are used in palliative care. So we’re trying to help replace the transportation option. Those things do just accumulate with age.

IT 102
article thumbnail

Sweet! A Metabolic Disorders focused podcast episode

PEMBlog

As always, I’m your host, Brad Sobolewski, and this episode focuses on the management of children with metabolic disorders who present to the emergency department. Therefore understanding these diseases, their presentations and their evaluation is critical for emergency medicine providers. On clinical presentation.

article thumbnail

Better Late Than Never – Unpacking FDA’s Highly Anticipated (and Long Overdue) Draft Guidance on Diversity Action Plans

FDA Law Blog

This could be based on differential pharmacokinetics (“PK”) or pharmacodynamics (“PD”), possible differences in susceptibility to specific adverse events of concern, or due to differential presentation of the disease or condition. providing language assistance); Reducing participant burden (e.g.,

Clinic 59
article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

Too many people do because it’s really hard to keep their loved ones at home for the cost, the enormous financial, mental and physical strain for the family. We present it to CMMI, to CMS, whoever will listen to us, people on The Hill. Diane: Which too many people do, Malaz. It has multiple prints and updates. ” You know?